Résultats de la recherche - 9 results

Assessment of the clinical and analytical performance of the Aptima SARS-CoV-2 assay using the VALCOR protocol.

a study protocol designed to set up a framework for test validation of SARS-CoV-2 virus assays. Using clinical samples collated from VALCOR, the performance of Aptima SARS-CoV-2 assay was assessed against ...

Validation of intra- and inter-laboratory reproducibility of the Xpert HPV assay according to the international guidelines for cervical cancer screening.

Guidelines as Topic Reproducibility of Results Sensitivity and Specificity Uterine Cervical Neoplasms Abstract: BACKGROUND Cervical cancer screening with assays detecting DNA of high-risk human papillomavirus ...

VALHUDES: A protocol for validation of human papillomavirus assays and collection devices for HPV testing on self-samples and urine samples

cervical precancer. However, insufficient evidence is available for specific HPV assay/self-sample device combinations. OBJECTIVES: The VALHUDES protocol is designed as a diagnostic test accuracy study that ...

Clinical Evaluation of INNO-LiPA HPV Genotyping II Assay Using the VALGENT Framework.

Neoplasms Abstract: In this diagnostic test validation study, we assessed the clinical accuracy and HPV genotyping performance of the INNO-LiPA HPV Genotyping II (INNO-LiPA) within the VALGENT-3 framework. ...

Performance of a Cartridge-Based Assay for Detection of Clinically Significant Human Papillomavirus (HPV) Infection: Lessons from VALGENT (Validation of HPV Genotyping Tests).

(VALGENT) studies offer an opportunity to clinically validate HPV assays for use in primary screening for cervical cancer and also provide a framework for the comparison of analytical and type-specific ...

Clinical and analytical performance of the PapilloCheck HPV-Screening assay using the VALGENT framework.

context is essential, using well-annotated samples, such as those generated via the Validation of Genotyping Tests- HPV (VALGENT) framework. OBJECTIVE: Our aim was to assess the PapilloCheck HPV assay in ...

VALGENT: A protocol for clinical validation of human papillomavirus assays.

Vaginal Smears Validation Studies as Topic Abstract: BACKGROUND: Testing for high-risk HPV is more effective in primary cervical cancer screening than the cytological examination of a Pap smear. Separate ...

Clinical evaluation of a GP5+/6+-based luminex assay having full high-risk human papillomavirus genotyping capability and an internal control.

0.6% inadequate specimens. Based on our study results, we consider the LMNX, similarly to the EIA, useful for HPV-based cervical cancer screening. Health Topics:  Cancer Cancer Kanker Quality of ...

QR code

QR code for this page URL